U.S. Non-opioid Pain Treatment Market Size & Outlook
U.S. non-opioid pain treatment market, 2018-2030 (US$M)
Related Markets
U.S. non-opioid pain treatment market highlights
- The U.S. non-opioid pain treatment market generated a revenue of USD 1,712.6 million in 2024 and is expected to reach USD 1,523.5 million by 2030.
- The U.S. market is expected to grow at a CAGR of -3.8% from 2025 to 2030.
- In terms of segment, other drug class was the largest revenue generating drug class in 2024.
- Local Anesthetics is the most lucrative drug class segment registering the fastest growth during the forecast period.
Non-opioid pain treatment market data book summary
| Market revenue in 2024 | USD 1,712.6 million |
| Market revenue in 2030 | USD 1,523.5 million |
| Growth rate | -3.8% (CAGR from 2025 to 2030) |
| Largest segment | Other drug class |
| Fastest growing segment | Local Anesthetics |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Acetaminophen, Local Anesthetics, Other Drug Class, NSAIDs |
| Key market players worldwide | Novartis AG ADR, Teva Pharmaceutical Industries Ltd, Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries, GSK PLC ADR, Pfizer Inc, Perrigo Co PLC, LNK International Inc., Cipla Ltd DR, Johnson & Johnson, Pacira BioSciences Inc, Pierrel S.p.A |
Other key industry trends
- Country-wise, France is expected to lead the global market in terms of revenue in 2030.
- In North America, Canada non-opioid pain treatment market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 1,523.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Non-opioid Pain Treatment Market Scope
Non-opioid Pain Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. non-opioid pain treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non-opioid pain treatment market will help companies and investors design strategic landscapes.
Other drug class was the largest segment with a revenue share of 43.27% in 2024. Horizon Databook has segmented the U.S. non-opioid pain treatment market based on acetaminophen, local anesthetics, other drug class, nsaids covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to U.S. non-opioid pain treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. non-opioid pain treatment market databook
-
Our clientele includes a mix of non-opioid pain treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. non-opioid pain treatment market , including forecasts for subscribers. This country databook contains high-level insights into U.S. non-opioid pain treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. non opioid pain treatment market report size, by drug class, 2018-2030 (US$M)
U.S. Non-opioid Pain Treatment Market Outlook Share, 2024 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
